Alithea Genomics Closes CHF 6.9 M Seed Round, Using Proceeds to Unlock Industrial-Scale RNA-seq for Primary Drug Screening and Toxicology

Alithea Genomics Closes CHF 6.9 M Seed Round, Using Proceeds to Unlock Industrial-Scale RNA-seq for Primary Drug Screening and Toxicology

LAUSANNE, Switzerland--(BUSINESS WIRE)--Mar 4, 2026-- Alithea Genomics, an emerging leader in the field of large-scale RNA sequencing and transcriptomics, announced today the closing of its seed financing round with an additional CHF 3 million ($3.9 million),…

LAUSANNE, Switzerland--(BUSINESS WIRE)--Mar 4, 2026-- Alithea Genomics, an emerging leader in the field of large-scale RNA sequencing and transcriptomics, announced today the closing of its seed fin… [+4651 chars]
Alithea Genomics Closes CHF 6.9 M Seed Round, Using Proceeds to Unlock Industrial-Scale RNA-seq for Primary Drug Screening and Toxicology - FHMnews